Tag Archives: ACBFF

Hot Warren Buffett Stocks To Own For 2019

Famed investor Warren Buffett loves Apple (NASDAQ:AAPL) stock. The Oracle of Omaha has been steadily increasing Berkshire Hathaway’s (NYSE:BRK-A) (NYSE:BRK-B) stake over the past couple of years, and it sounds like Buffett has no intention of putting the brakes on buying Apple shares. Berkshire hosted its annual meeting over the weekend, and as usual Buffett offered up some sage advice to investors looking to emulate his returns.

This morning, Buffett even went as far as to say that he’d like to own all of Apple if he could.

Image source: Apple.

Buffett wants the whole thing

“We bought about 5% of the company. I’d love to own 100% of it,” Buffett said about the Mac maker in an interview with CNBC. “That’s the test: Would you like to own 100% of a company?” Of course, owning 100% of Apple is far too tall of an order to fill, with shares tapping all-time highs following Buffett’s endorsement and pegging Apple’s market cap at around $900 billion. Not even Warren Buffett has that kind of money at his disposal.

Hot Warren Buffett Stocks To Own For 2019: Calumet Specialty Products Partners L.P.(CLMT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is estimated to report quarterly loss at $0.36 per share on revenue of $757.65 million.

    Pointer Telocation Ltd. (NASDAQ: PNTR) is projected to report quarterly earnings at $0.22 per share on revenue of $20.22 million.

  • [By Stephan Byrd]

    Calumet Specialty Products Partners (NASDAQ:CLMT) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a research report issued on Saturday.

  • [By Tyler Crowe]

    Whenever a company is in the midst of a multiyear turnaround plan like Calumet Specialty Products Partners (NASDAQ:CLMT), some quarters are going to show more progress than others. This past quarter was one of those less noticeable quarters as many of the moves it made were a detriment to the bottom line. Nevertheless, there were some reasons investors should be satisfied with what Calumet did in the quarter.

  • [By Tyler Crowe]

    After years of languishing in penny stock territory, shares of Calumet Specialty Products Partners (NASDAQ:CLMT) have had a nice run over the past year as its income statement is starting to show the results of management’s turnaround program. This past quarter, the company’s headline numbers didn’t quite show the progress we have seen in prior ones, but there are still reasons to believe that things are picking up at this specialty chemical producer and oil refiner.

Hot Warren Buffett Stocks To Own For 2019: Eaton Vance New York Municipal Bond Fund(ENX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Eaton Vance New York Municipal Bond Fund (NYSEAMERICAN:ENX) announced a monthly dividend on Thursday, July 5th, Wall Street Journal reports. Investors of record on Tuesday, July 24th will be paid a dividend of 0.0448 per share on Tuesday, July 31st. This represents a $0.54 dividend on an annualized basis and a dividend yield of 4.75%. The ex-dividend date of this dividend is Monday, July 23rd.

  • [By Logan Wallace]

    Eaton Vance New York Municipal Bond Fund (NYSEAMERICAN:ENX) announced a monthly dividend on Wednesday, October 3rd, Wall Street Journal reports. Shareholders of record on Wednesday, October 24th will be paid a dividend of 0.0448 per share on Wednesday, October 31st. This represents a $0.54 annualized dividend and a yield of 4.91%. The ex-dividend date of this dividend is Tuesday, October 23rd.

  • [By Logan Wallace]

    Eaton Vance New York Municipal Bond Fund (NYSEAMERICAN:ENX) announced a monthly dividend on Monday, June 4th, Wall Street Journal reports. Shareholders of record on Friday, June 22nd will be given a dividend of 0.0448 per share on Friday, June 29th. This represents a $0.54 annualized dividend and a yield of 4.77%. The ex-dividend date of this dividend is Thursday, June 21st.

  • [By Joseph Griffin]

    Euronext Amsterdam (EPA:ENX) has been assigned a €51.00 ($60.71) price target by investment analysts at UBS in a note issued to investors on Wednesday, www.boersen-zeitung.de reports. The firm presently has a “sell” rating on the stock. UBS’s target price would suggest a potential downside of 15.63% from the stock’s current price.

  • [By Joseph Griffin]

    Eaton Vance New York Municipal Bond Fund (NYSEAMERICAN:ENX) declared a monthly dividend on Monday, February 4th, Wall Street Journal reports. Shareholders of record on Thursday, February 21st will be paid a dividend of 0.0415 per share on Thursday, February 28th. This represents a $0.50 annualized dividend and a dividend yield of 4.39%. The ex-dividend date of this dividend is Wednesday, February 20th.

Hot Warren Buffett Stocks To Own For 2019: 8point3 Energy Partners LP(CAFD)

Advisors’ Opinion:

  • [By Logan Wallace]

    Cent PUERTO S AS (NYSE:CEPU) and 8Point3 Energy Partners (NASDAQ:CAFD) are both small-cap oils/energy companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation and institutional ownership.

Hot Warren Buffett Stocks To Own For 2019: Aurora Cannabis Inc. (ACBFF)

Advisors’ Opinion:

  • [By ]

    Toronto-listed Aurora (ACBFF) announced Monday that it had agreed to buy MedReleaf Corp. in an all-stock transaction valued at approximately C$3.2 billion ($2.5 billion). The deal is the largest in the cannabis sector to date and Aurora’s eighth transaction in just over a year.

  • [By Keith Speights]

    There has been a wave of acquisitions among Canadian marijuana growers so far in 2018. The most recent — and biggest — is Aurora Cannabis’ (NASDAQOTH:ACBFF) planned buyout of MedReleaf. But will the acquisition fever cool off? Don’t count on it.

  • [By George Budwell]

    Since going public in July, the company’s shares have appreciated by a mind-boggling 130%. As a result, Tilray is now the third-largest marijuana company in the world after fellow Canadian growers Canopy Growth Corporation (NYSE:CGC) (TSX:WEED) and Aurora Cannabis Inc. (NASDAQOTH:ACBFF).

Hot Warren Buffett Stocks To Own For 2019: Principal Financial Group Inc(PFG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    KBC Group NV lowered its position in shares of Principal Financial Group Inc (NYSE:PFG) by 41.4% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 201,808 shares of the financial services provider’s stock after selling 142,313 shares during the period. KBC Group NV’s holdings in Principal Financial Group were worth $12,292,000 as of its most recent filing with the SEC.

  • [By Max Byerly]

    Shore Capital reissued their hold rating on shares of Provident Financial (LON:PFG) in a report issued on Thursday.

    PFG has been the subject of several other reports. Liberum Capital reissued a sell rating and set a GBX 483 ($6.48) price objective on shares of Provident Financial in a research note on Monday, February 26th. Peel Hunt reissued a hold rating and set a GBX 870 ($11.67) price objective on shares of Provident Financial in a research note on Tuesday, February 27th. JPMorgan Chase & Co. reduced their price objective on Provident Financial from GBX 1,100 ($14.76) to GBX 750 ($10.06) and set a neutral rating for the company in a research note on Thursday, May 10th. Barclays reissued an underweight rating and set a GBX 584 ($7.84) price objective on shares of Provident Financial in a research note on Wednesday, January 31st. Finally, Societe Generale lowered Provident Financial to a hold rating and set a GBX 1,050 ($14.09) price objective for the company. in a research note on Wednesday, February 28th. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have assigned a buy rating to the company’s stock. Provident Financial presently has a consensus rating of Hold and a consensus price target of GBX 1,190.14 ($15.97).

  • [By Joseph Griffin]

    Sawtooth Solutions LLC bought a new position in Principal Financial Group Inc (NYSE:PFG) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm bought 17,428 shares of the financial services provider’s stock, valued at approximately $922,000.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Principal Financial Group (PFG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    ING Groep NV boosted its stake in Principal Financial Group Inc (NYSE:PFG) by 7.8% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 27,524 shares of the financial services provider’s stock after purchasing an additional 1,991 shares during the period. ING Groep NV’s holdings in Principal Financial Group were worth $1,676,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Logan Wallace]

    Provident Financial plc (LON:PFG) has received a consensus recommendation of “Hold” from the fifteen research firms that are covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, eleven have given a hold recommendation and two have given a buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is GBX 1,244.33 ($16.57).

Hot Warren Buffett Stocks To Own For 2019: Clean Energy Fuels Corp.(CLNE)

Advisors’ Opinion:

  • [By Paul Ausick]

    Clean Energy Fuels Corp. (NASDAQ: CLNE) saw a drop of 1.3% in short interest to 3.45 million shares. About 4.1% of the company’s float was short and days to cover fell from two to one. The share price jumped 24.7% in the two-week period. The stock closed at $2.80 on Wednesday, down about 1.2% for the day, in a 52-week range of $1.31 to $4.05.

  • [By Jon C. Ogg]

    Clean Energy Fuels Corp. (NASDAQ: CLNE) was downgraded to Underperform from Market Perform at Raymond James. Its shares closed up 1.6% at $3.71 on Tuesday but were indicated down 4% at $3.56 on Thursday.

  • [By Paul Ausick]

    Clean Energy Fuels Corp. (NASDAQ: CLNE) saw a small rise of 0.6% in short interest to 3.91 million shares. About 4.5% of the company’s float was short and  the number of days to cover fell from two to one. The share price soared 55.4% in the two-week period until May 31. The stock’s price was $2.99 at Monday’s market close, down about 3.5% for the day, within a 52-week range of $1.31 to $3.52.

  • [By Tyler Crowe, Jason Hall, and Matthew DiLallo]

    So we asked three of our Motley Fool contributors to each highlight a stock they think is a top buy this month. Here’s why they picked Williams Companies (NYSE:WMB), Clean Energy Fuels (NASDAQ:CLNE), and SolarEdge Technologies (NASDAQ:SEDG)

Top 5 Clean Energy Stocks To Own Right Now

What happened 

Shares of natural gas distributor Clean Energy Fuels Corp. (NASDAQ:CLNE) were down 10.2% at the close of trading Monday on no real news. Shares were down as much as 11.8% in early morning trading, and were down by high single digits for most of the day. 

So what

Oddly enough, crude oil is trading slightly higher today with WTI crude up 0.3% and Brent crude up 1.5% on the day, which is usually a bullish sign for Clean Energy Fuels. Natural gas is also down 1%, which should lower input costs, another factor that usually pushes the stock higher. 

Image source: Getty Images.

Sometimes stocks trade on momentum or factors that have nothing to do with fundamentals, and that appears to be what’s happening today. Shares were also down double digits last Thursday on an analyst downgrade, so this could be momentum from that move as well. 

Top 5 Clean Energy Stocks To Own Right Now: Adaptimmune Therapeutics plc(ADAP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Adaptimmune Therapeutics (NASDAQ:ADAP) was downgraded by stock analysts at TheStreet from a “c-” rating to a “d+” rating in a research report issued to clients and investors on Monday.

  • [By Logan Wallace]

    Adaptimmune Therapeutics (NASDAQ:ADAP) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday.

  • [By Ethan Ryder]

    Adaptimmune Therapeutics (NASDAQ:ADAP) announced its quarterly earnings data on Wednesday. The biotechnology company reported ($0.04) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.24) by $0.20, Bloomberg Earnings reports. Adaptimmune Therapeutics had a negative return on equity of 32.26% and a negative net margin of 185.39%. During the same quarter in the prior year, the business earned ($3.00) EPS.

  • [By ]

    Adaptimmune Therapeutics (ADAP) : “If you’ve speculated on this one, you’ve won. Let’s move on.”

    Icahn Enterprises (IEP) : “I don’t really know what they own so I can’t recommend it.”

  • [By Logan Wallace]

    Here are some of the news stories that may have impacted Accern Sentiment Analysis’s rankings:

    Get Adaptimmune Therapeutics alerts:

    Analysts Anticipate Adaptimmune Therapeutics PLC – (ADAP) to Post -$0.28 Earnings Per Share (americanbankingnews.com) Peritoneal Cancer Market Pipeline Review H1- Target Drug Profile, Top Industry Intelligence, Major Key Players and … (thefreenewsman.com) Escherichia coli Infections Market Research Report Pipeline Review H1 Assessment by Mechanism of Action, Drug … (theperfectinvestor.com) Adaptimmune Therapeutics plc (ADAP): Do You Have This Stock in Portfolio?: (bitcoinpriceupdate.review)

    Several equities analysts have weighed in on the company. Leerink Swann reissued an “outperform” rating on shares of Adaptimmune Therapeutics in a report on Thursday, March 15th. BidaskClub downgraded Adaptimmune Therapeutics from a “hold” rating to a “sell” rating in a research report on Wednesday. ValuEngine upgraded Adaptimmune Therapeutics from a “buy” rating to a “strong-buy” rating in a research report on Monday. SunTrust Banks increased their target price on Adaptimmune Therapeutics to $18.00 and gave the stock a “buy” rating in a research report on Thursday, May 10th. Finally, Cowen restated a “buy” rating on shares of Adaptimmune Therapeutics in a research report on Wednesday, May 9th. Two equities research analysts have rated the stock with a sell rating, four have given a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $16.94.

  • [By ]

    Cramer was bearish on Chesapeake Energy (CHK) , Adaptimmune Therapeutics (ADAP) , Icahn Enterprises (IEP) , Bristol-Myers Squibb (BMY) , Quad/Graphics (QUAD) , Spectra Energy Partners (SEP) and L Brands (LB) .

Top 5 Clean Energy Stocks To Own Right Now: TerraForm Power, Inc.(TERP)

Advisors’ Opinion:

  • [By Shane Hupp]

    Entergy (NYSE: ETR) and TerraForm Power (NASDAQ:TERP) are both utilities companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, earnings, profitability, dividends, risk, institutional ownership and analyst recommendations.

  • [By Matthew DiLallo]

    Brookfield Renewable Partners is one of the largest publicly traded renewable power generators in the world. The company focuses on producing hydropower, which currently comprises 76% of its portfolio, though it also has exposure to the wind and solar markets, due in part to its investment in TerraForm Power (NASDAQ:TERP). Brookfield sells about 87% of the power it produces under long-term contracts, which lock in prices, thus allowing it to generate stable cash flow. The company currently pays out about 90% of that cash to investors to support its high-yielding distribution, but aims to get that number down to 70% over the long term.

  • [By Matthew DiLallo]

    TerraForm Power (NASDAQ:TERP) has come a long way since Brookfield Asset Management (NYSE:BAM) took control of the renewable-power-generating company last fall. At the time, the pair unveiled an ambitious turnaround plan to improve TerraForm’s legacy operations and reposition it for future growth. That strategy is working out even better than the companies initially anticipated, which was evident in its second-quarter report.

  • [By Tyler Crowe, Sean Williams, and Brian Stoffel]

    So we asked three Motley Fool contributors to highlight a stock they think is a great dividend investment today. Here’s why they picked Big Lots (NYSE:BIG), Enviva Partners (NYSE:EVA), and TerraForm Power (NASDAQ:TERP). 

  • [By Matthew DiLallo]

    In addition to the embedded growth within its existing portfolio, Brookfield Renewable has the potential to continue making acquisitions to power an even faster growth rate. Brookfield has a long history of making needle-moving deals, including closing several in the last year. In October, it invested $203 million to acquire a 16% stake in wind and solar company TerraForm Power (NASDAQ:TERP). It followed that up by spending $230 million for a 31% interest in TerraForm Global in December and then boosting its stake in TerraForm Power up to 31% this summer by investing another $217 million into that company.

Top 5 Clean Energy Stocks To Own Right Now: Hawaiian Telcom Holdco, Inc.(HCOM)

Advisors’ Opinion:

  • [By Max Byerly]

    News coverage about Hawaiian Telcom HoldCo (NASDAQ:HCOM) has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Hawaiian Telcom HoldCo earned a news impact score of 0.06 on Accern’s scale. Accern also assigned media coverage about the utilities provider an impact score of 46.776618457707 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Top 5 Clean Energy Stocks To Own Right Now: NETGEAR, Inc.(NTGR)

Advisors’ Opinion:

  • [By Max Byerly]

    Netgear (NASDAQ:NTGR) has received a consensus recommendation of “Buy” from the seven brokerages that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, five have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $74.50.

  • [By Max Byerly]

    ValuEngine upgraded shares of NetGear (NASDAQ:NTGR) from a hold rating to a buy rating in a research report sent to investors on Tuesday morning.

    Other analysts also recently issued research reports about the stock. BidaskClub downgraded shares of NetGear from a strong-buy rating to a buy rating in a research report on Tuesday, June 26th. TheStreet downgraded shares of NetGear from a b- rating to a c+ rating in a research report on Monday, August 13th. Raymond James set a $80.00 target price on shares of NetGear and gave the stock a buy rating in a research report on Wednesday, September 5th. Cowen assumed coverage on shares of NetGear in a research report on Monday. They set a hold rating and a $63.00 target price for the company. Finally, Zacks Investment Research raised shares of NetGear from a strong sell rating to a hold rating in a research report on Wednesday, June 27th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the company’s stock. The company presently has an average rating of Hold and an average price target of $70.40.

  • [By Ethan Ryder]

    Silvercrest Asset Management Group LLC lowered its stake in shares of NetGear, Inc. (NASDAQ:NTGR) by 99.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,386 shares of the communications equipment provider’s stock after selling 840,960 shares during the quarter. Silvercrest Asset Management Group LLC’s holdings in NetGear were worth $480,000 at the end of the most recent reporting period.

Top 5 Clean Energy Stocks To Own Right Now: Aurora Cannabis Inc. (ACBFF)

Advisors’ Opinion:

  • [By Keith Speights]

    Other Canadian marijuana growers could also jump into the fray. Last month, BNN Bloomberg reported that Molson Coors (NYSE:TAP) was in discussions with several Canadian companies, including Aurora Cannabis (NASDAQOTH:ACBFF) and Aphria (NASDAQOTH:APHQF), about collaborating on cannabis-infused beverages. The report also indicated that Molson Coors was potentially interested in investing in a Canadian marijuana grower, as Constellation Brands did.

  • [By Shanthi Rexaline]

    Aurora Cannabis Inc (OTC: ACBFF) recently announced a deal to buy MedReleaf Corp (OTC: MEDFF) in an all-cash transaction valued at C$3.2 billion.

  • [By Sean Williams]

    The bigger catalyst was the announcement that Aurora Cannabis (NASDAQOTH:ACBFF) would buy MedReleaf in an all-share deal valued at around $2.5 billion. Although the deal hasn’t closed, it represents a healthy premium from where MedReleaf had been trading when the deal was announced. It would also give Aurora Cannabis a genuine shot to lead all growers in annual production. Aurora Cannabis estimates that the combined entity would be capable of 570,000 kilograms of cannabis production a year when at full capacity. 

  • [By Keith Speights]

    Marijuana grower

    Canopy Growth Corporation (NYSE:CGC) $5.8 billion
      Aurora Cannabis (NASDAQOTH: ACBFF) $2.9 billion
      Tilray (NASDAQ: TLRY) $2.3 billion
      Aphria (NASDAQOTH: APHQF) $1.9 billion
      MedMen Enterprises (NASDAQOTH: MMNFF) $1.3 billion
      Cronos Group (NASDAQ: CRON) $1 billion
      The Green Organic Dutchman (NASDAQOTH: TGODF) $1 billion
      The Hydropothecary (NASDAQOTH: HYYDF) $728 million
      CannTrust Holdings (NASDAQOTH: CNTTF) $513 million
      Organigram Holdings (NASDAQOTH: OGRMF) $509 million
      Marimed (NASDAQOTH: MRMD) $472 million
      TerrAscend (NASDAQOTH: TRSSF) $398 million
      Auxly Cannabis (NASDAQOTH: CBWTF) $368 million
      iAnthus Capital Holdings (NASDAQOTH: ITHUF) $367 million
      Medical Marijuana (NASDAQOTH: MJNA) $330 million
      CV Sciences (NASDAQOTH: CVSI) $299 million
      Emerald Health Therapeutics (NASDAQOTH: EMHTF) $287 million
      Supreme Cannabis (NASDAQOTH: SPRWF) $277 million
      Smart Cannabis (NASDAQOTH: SCNA) $276 million
      MPX Bioceutical (NASDAQOTH: MPXEF) $234 million
      AusCann Group Holdings (NASDAQOTH: ACNNF) $223 million
      Liberty Health Sciences (NASDAQOTH: LHSIF) $213 million

    Biotech

Top Performing Stocks To Own For 2019

I’m not betting against Lululemon Athletica (NASDAQ:LULU) at this point. I wouldn’t recommend anyone else do so, either. LULU stock has risen 150% from November lows — and the gains have been deserved.

Lululemon has been performing exceedingly well, including a ridiculous 20% same-store sales increase in the first quarter. As Will Ashworth detailed, the company made a strong choice in new CEO Calvin McDonald. Athleisure remains hot in the U.S., and international growth is torrid.

Indeed, even I — a longtime retail bear — came around to the LULU story after the company’s Q4 report in March. But LULU stock has tacked on 70% gains since then. And as much as I like the company, and the story, I see some reason for caution, at least, ahead of Thursday afternoon’s fiscal Q2 report.

The Case for LULU Into Earnings

The case for buying — or keeping — LULU stock into earnings is relatively simple. Don’t fight the tape, or the trend. The company is performing exceedingly well, and there’s no reason to see that trend changing. Indeed, last week, Gap (NYSE:GPS) cited a strong quarter for its Athleta brand. That bodes well for Lululemon, given its much larger reach and far stronger sales.

Top Performing Stocks To Own For 2019: Aurora Cannabis Inc. (ACBFF)

Advisors’ Opinion:

  • [By Sean Williams]

    There are currently more than 90 licensed cultivators in Canada, and this figure is only expected to grow. Many of these growers have been using every ounce of capital available, as well as utilizing bought-deal offerings to raise additional capital to expand their growing capacity. Six of the largest projected producers — Canopy Growth Corp (NASDAQOTH:TWMJF), Aurora Cannabis (NASDAQOTH:ACBFF), Aphria, MedReleaf, OrganiGram Holdings, and Hydropthecary Corp. — are expected to generate around 1.17 million kilograms per year by 2020.

  • [By Keith Speights]

    Aurora Cannabis (NASDAQOTH:ACBFF) is in serious talks with Coca-Cola to develop cannabis-infused beverages, according to a report by BNN Bloomberg TV. Could a deal with Coke and Aurora be even bigger news than Constellation Brands’ (NYSE:STZ) partnership with Canopy Growth (NYSE:CGC)? 

  • [By Sean Williams]

    If you ignore the share price and focus on market cap instead, Aurora Cannabis (NASDAQOTH:ACBFF) and its nearly $7 billion market cap look to be nearly priced for perfection.

Top Performing Stocks To Own For 2019: THL Credit, Inc.(TCRD)

Advisors’ Opinion:

  • [By Max Byerly]

    THL Credit, Inc. (NASDAQ:TCRD) CFO Terrence W. Olson acquired 10,200 shares of the business’s stock in a transaction on Wednesday, May 9th. The stock was acquired at an average price of $7.80 per share, for a total transaction of $79,560.00. The acquisition was disclosed in a document filed with the SEC, which is available at this link.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on THL Credit (TCRD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    THL Credit, Inc. (NASDAQ:TCRD) CFO Terrence W. Olson purchased 11,511 shares of the firm’s stock in a transaction on Friday, May 11th. The stock was bought at an average price of $7.86 per share, for a total transaction of $90,476.46. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website.

  • [By Max Byerly]

    Thl Credit (NASDAQ: TCRD) and Tian Ge Interactiv (OTCMKTS:TGRVF) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, profitability, risk, institutional ownership and valuation.

Top Performing Stocks To Own For 2019: Neogen Corporation(NEOG)

Advisors’ Opinion:

  • [By Max Byerly]

    NEO GOLD (CURRENCY:NEOG) traded 3.7% lower against the US dollar during the 24 hour period ending at 16:00 PM ET on May 21st. NEO GOLD has a market cap of $0.00 and approximately $162.00 worth of NEO GOLD was traded on exchanges in the last 24 hours. One NEO GOLD token can currently be bought for about $0.0019 or 0.00000023 BTC on major exchanges. Over the last seven days, NEO GOLD has traded 10.9% lower against the US dollar.

  • [By Stephan Byrd]

    Neogen Co. (NASDAQ:NEOG) has been given a consensus recommendation of “Buy” by the six research firms that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a strong buy rating to the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $65.67.

  • [By Ethan Ryder]

    Trinity Biotech (NASDAQ: TRIB) and Neogen (NASDAQ:NEOG) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings and analyst recommendations.

  • [By Garrett Baldwin]

    Three Stocks to Watch Today: NKE, KORS, GE

    Shares of Nike Inc. (NYSE: NKE) are on the move ahead of today’s earnings report. Wall Street expects that the apparel giant will report earnings per share of $0.62 on top of $9.87 billion in revenue. Investors will be hanging on every word of the conference call as markets weigh the success of the company’s latest ad campaign featuring Colin Kaepernick. In addition, investors will be curious if the firm received a boost by the Tour Championship victory over the weekend by Tiger Woods, who won his first golf tournament in five years. Michael Kors Holdings Ltd. (NYSE: KORS) just made another huge acquisition. According to reports, it purchased the iconic Gianni Versace brand in a deal worth $2.1 billion. The deal gives Kors a gateway to the high-end European luxury market. Shares of General Electric Co. (NYSE: GE) are sitting at nine-year lows as the company’s power business struggles. Shares hit their lowest levels since July 13, 2009 as the firm grapples with a failed gas turbine in Texas. The turbine’s failure fueled a stock downgrade by JPMorgan Chase & Co. (NYSE: GE) last week. Look for earnings reports from Carnival Corp. (NYSE: CCL), KB Home (NYSE: KBH), FactSet Research Systems Inc. (NYSE: FDS), Jabil Inc. (NYSE: JBL), Cintas Corp. (NASDAQ: CTAS), AAR Corp. (NYSE: AIR), Neogen Corp. (NASDAQ: NEOG), and IHS Markit Ltd. (NYSE: INFO).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Logan Wallace]

    Neogen (NASDAQ:NEOG) has been assigned a consensus recommendation of “Hold” from the seven analysts that are covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation, one has issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $62.33.

Top Performing Stocks To Own For 2019: tronc, Inc. (TRNC)

Advisors’ Opinion:

  • [By Chris Hill]

    Unemployment hits a 49-year low. Tech giants may have been hacked by China. Elon Musk’s tweeting sends Tesla (NASDAQ:TSLA) shares lower. Costco (NASDAQ:COST) struggles with “material weakness.” And Tronc (NASDAQ:TRNC) decides to change its name back to Tribune Publishing.

  • [By Douglas A. McIntyre]

    Tronc Inc. (NASDAQ: TRNC), the owner of the Lost Angeles Times, agreed to sell the paper to billionaire Patrick Soon-Shiong, who is also one of Tronc’s largest shareholders. The deal, for $500 million and the assumption of about $90 million in pension liabilities, was announced on February 7. The Federal Trade Commission and U.S. Department of Justice blessed the deal on March 7, almost two months ago.

  • [By Douglas A. McIntyre]

    The sale of the Los Angeles Times and several smaller newspapers by Tronc Inc. (NASDAQ: TRNC) to Dr. Patrick Soon-Shiong closed after months of worry.

  • [By Stephan Byrd]

    News coverage about tronc (NASDAQ:TRNC) has trended somewhat positive recently, according to Accern. Accern identifies negative and positive press coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. tronc earned a daily sentiment score of 0.03 on Accern’s scale. Accern also gave media headlines about the company an impact score of 47.3907920123643 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

  • [By Douglas A. McIntyre]

    Newspaper publisher Tronc Inc. (NASDAQ: TRNC) may have a new controlling shareholder. According to the New York Post:

    McCormick Media, which already has a definitive agreement to buy the 25.7 percent of Tronc stock owned by ex-chairman Michael Ferro, is in talks with another “significant” shareholder about increasing its stake even further.

Top Casino Stocks To Watch For 2019

Related LVS 5 Trends U.S. Casino Investors Need To Watch Deutsche Bank Says Buy MGM Following SotP Analysis, 'Encouraging' Q4 Metrics Macau at the crossroads (Seeking Alpha)
Related Benzinga's Top Upgrades Morgan Stanley Revises Triple-Net REIT Ratings Prior To Q2 Earnings

One of the more unique technical analysis metrics used to determine buy and sell signals is Parabolic SAR. Developed by Welles Wilder in 1978, the “SAR” stands for “stop and reverse.”

Top Casino Stocks To Watch For 2019: Globus Medical, Inc.(GMED)

Advisors’ Opinion:

  • [By Logan Wallace]

    Globus Medical Inc (NYSE:GMED) – Research analysts at William Blair cut their Q2 2018 earnings per share (EPS) estimates for shares of Globus Medical in a report released on Thursday, May 3rd. William Blair analyst K. Krum now forecasts that the medical device company will earn $0.35 per share for the quarter, down from their previous estimate of $0.37. William Blair also issued estimates for Globus Medical’s Q3 2018 earnings at $0.35 EPS, FY2018 earnings at $1.52 EPS, Q1 2019 earnings at $0.42 EPS, Q3 2019 earnings at $0.42 EPS, Q4 2019 earnings at $0.46 EPS and FY2019 earnings at $1.71 EPS.

  • [By Joseph Griffin]

    Schwab Charles Investment Management Inc. raised its stake in shares of Globus Medical Inc (NYSE:GMED) by 8.0% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 421,775 shares of the medical device company’s stock after purchasing an additional 31,253 shares during the period. Schwab Charles Investment Management Inc. owned 0.44% of Globus Medical worth $21,013,000 at the end of the most recent reporting period.

Top Casino Stocks To Watch For 2019: New York REIT, Inc.(NYRT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Media coverage about New York REIT (NYSE:NYRT) has been trending somewhat positive this week, according to Accern. The research firm ranks the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. New York REIT earned a daily sentiment score of 0.12 on Accern’s scale. Accern also gave media headlines about the real estate investment trust an impact score of 46.2668688678986 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

  • [By Joseph Griffin]

    Media headlines about New York REIT (NYSE:NYRT) have been trending somewhat positive recently, Accern Sentiment reports. Accern rates the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. New York REIT earned a news impact score of 0.17 on Accern’s scale. Accern also gave news coverage about the real estate investment trust an impact score of 46.6379734958041 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Max Byerly]

    New York REIT (NYSE:NYRT) reached a new 52-week high and low on Monday . The stock traded as low as $17.51 and last traded at $17.60, with a volume of 7341 shares traded. The stock had previously closed at $17.85.

Top Casino Stocks To Watch For 2019: Aurora Cannabis Inc. (ACBFF)

Advisors’ Opinion:

  • [By Sean Williams]

    Perhaps no company will be guiltier of drowning its investors in share dilution more than Aurora Cannabis (NASDAQOTH:ACBFF). After finishing fiscal 2014 with just over 16 million shares outstanding, Aurora Cannabis ended the third quarter of fiscal 2018 with almost 565 million shares outstanding. Having recently announced an all-share acquisition of MedReleaffor what amounted to $2.5 billion at the time, Aurora Cannabis could have in excess of 1 billion shares outstanding by this time next year. Aurora would have to earn CA$100 million ($77 million) just to generate $0.10 in annual EPS. That’s insane, and it’s all the more reason to avoid it and a handful of dilution-happy pot stocks.

  • [By Sean Williams]

    For example, Aurora Cannabis (NASDAQOTH:ACBFF) has suggested that it could lead the pack by producing 570,000 kilograms of cannabis-equivalent production yearly, when at full capacity. But when Oct. 17 rolls around, it’s not going to be anywhere near this level. Its 800,000-square-foot Aurora Sky facility will be done by then, and it’s capable of just over 100,000 kilograms of cannabis production annually, but its recently announced Aurora Sun facility in Alberta, and its partnered Aurora Nordic project, won’t be completely online until a later date.

  • [By ]

    What are the risks? First off, the Cannabis market in Canada is already competitive, and it’s the fifth largest company behind the likes of Canopy (OTCPK:TWMJF), Aurora (OTCQX:ACBFF), Aphria (OTCQB:APHQF), Medreleaf (OTCPK:MEDFF), and Cronos (OTC:CRON). What’s more, there are approximately 228 million fully diluted shares, selling at $3.16/share ($4.04/share $CAD), and the company generated $CAD4.09mm in 2017 revenues. That’s quite a premium, and Hydropothecary Corp. trades expensively at a 225x sales multiple. Caveat emptor.

  • [By Sean Williams]

    Over the past year and change, three cannabis growers have maintained their position near the head of the pack in terms of production: Aurora Cannabis (NASDAQOTH:ACBFF), Canopy Growth Corporation, and Aphria. According to company estimates, Aurora Cannabis and Aphria are on track to produce 570,000 kilograms (assuming the completed purchase of MedReleaf (NASDAQOTH:MEDFF)) and 255,000 kilograms of cannabis annually, respectively, with Canopy Growth likely producing around 500,000 kilograms a year, by my best estimate.

  • [By Keith Speights]

    Big Canadian marijuana growers like Canopy Growth (NYSE:CGC), Aurora Cannabis (NASDAQOTH:ACBFF), and Aphria (NASDAQOTH:APHQF) aren’t building a baseball field in hopes that famous dead players will show up. However, they are cranking up production capacity in the hopes that there’ll be a huge demand for recreational marijuana in Canada.

  • [By ]

    As of the time of this writing, the average price to sales ratio of the large Canadian cannabis producers is 40 (Aurora (OTCQX:ACBFF): 33; Canopy (OTCPK:TWMJF): 65; Aphria (OTCQB:APHQF): 28.5; MedReleaf (OTCPK:MEDFF): 35). Given iAnthus’ vertical integration and lack of competition, their margins should be significantly better than any of those firms. However, since they operate in the US where there is greater legal risk, we will reduce that multiple by half. Assuming the low end of expected revenue for 2018 of $20 million, and a P/S of 20, we arrive at a valuation of $400,000,000, giving us a one year price target of $5/share.

Best Gold Stocks To Own Right Now

Deutsche Bank set a €17.00 ($20.24) price target on ING Group (AMS:INGA) in a research report report published on Thursday. The brokerage currently has a buy rating on the stock.

A number of other equities analysts have also recently commented on INGA. JPMorgan Chase set a €17.40 ($20.71) target price on ING Group and gave the stock a buy rating in a report on Wednesday. Royal Bank of Canada set a €16.50 ($19.64) price target on ING Group and gave the company a buy rating in a report on Wednesday. Credit Suisse Group set a €13.50 ($16.07) price target on ING Group and gave the company a sell rating in a report on Wednesday. Goldman Sachs set a €17.75 ($21.13) price target on ING Group and gave the company a buy rating in a report on Thursday. Finally, UBS set a €18.30 ($21.79) price target on ING Group and gave the company a buy rating in a report on Friday, January 19th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and eleven have given a buy rating to the company’s stock. The stock currently has an average rating of Buy and an average target price of €16.60 ($19.76).

Best Gold Stocks To Own Right Now: ArQule Inc.(ARQL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on ArQule (ARQL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    ArQule (NASDAQ:ARQL)‘s stock had its “buy” rating restated by equities researchers at Needham & Company LLC in a research report issued to clients and investors on Tuesday, Marketbeat Ratings reports. They currently have a $6.00 price target on the biotechnology company’s stock, up from their prior price target of $5.00. Needham & Company LLC’s price target suggests a potential upside of 134.38% from the company’s previous close.

  • [By Stephan Byrd]

    ArQule, Inc. (NASDAQ:ARQL) Director Ronald M. Lindsay acquired 23,900 shares of the company’s stock in a transaction on Thursday, May 10th. The stock was acquired at an average price of $2.67 per share, for a total transaction of $63,813.00. Following the purchase, the director now directly owns 43,900 shares of the company’s stock, valued at $117,213. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Best Gold Stocks To Own Right Now: ENGlobal Corporation(ENG)

Advisors’ Opinion:

  • [By Max Byerly]

    ENGlobal (NASDAQ:ENG) will be announcing its earnings results before the market opens on Wednesday, May 9th.

    ENGlobal (NASDAQ:ENG) last released its quarterly earnings data on Thursday, March 15th. The construction company reported ($0.08) earnings per share for the quarter. ENGlobal had a negative net margin of 29.16% and a negative return on equity of 17.18%. The firm had revenue of $14.43 million during the quarter.

Best Gold Stocks To Own Right Now: Provident Financial Services, Inc(PFS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Here are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:

    Get Provident Financial Services alerts:

    Head-To-Head Review: Provident Financial (PROV) versus Provident Financial Services (PFS) (americanbankingnews.com) Head-To-Head Contrast: Territorial Bancorp (TBNK) & Provident Financial Services (PFS) (americanbankingnews.com) Q3 2018 EPS Estimates for Provident Financial Services, Inc. Decreased by Piper Jaffray (PFS) (americanbankingnews.com) Provident Financial Services, Inc. (PFS) Given Average Rating of “Hold” by Brokerages (americanbankingnews.com)

    A number of research analysts have issued reports on PFS shares. Sandler O’Neill raised shares of Provident Financial Services from a “hold” rating to a “buy” rating and set a $29.00 price objective on the stock in a research report on Friday, January 26th. ValuEngine raised shares of Provident Financial Services from a “hold” rating to a “buy” rating in a research report on Wednesday, March 7th. Zacks Investment Research downgraded shares of Provident Financial Services from a “buy” rating to a “hold” rating in a research report on Wednesday, February 21st. Boenning Scattergood reissued a “hold” rating on shares of Provident Financial Services in a research report on Monday, January 29th. Finally, Piper Jaffray reissued a “hold” rating and set a $28.00 price objective on shares of Provident Financial Services in a research report on Tuesday, January 9th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. Provident Financial Services currently has a consensus rating of “Hold” and an average price target of $28.42.

Best Gold Stocks To Own Right Now: Aurora Cannabis Inc. (ACBFF)

Advisors’ Opinion:

  • [By Sean Williams]

    Not too far behind Canopy Growth is Aurora Cannabis (NASDAQOTH:ACBFF), which has grown every which way over the past year, and is on track to deliver more than 430,000 kilograms in fully funded capacity.

  • [By Keith Speights]

    Even Canadian marijuana stocks that don’t have significant U.S. ties received a boost. The share prices of the two largest Canadian marijuana growers by market cap, Canopy Growth (NASDAQOTH:TWMJF) and Aurora Cannabis (NASDAQOTH:ACBFF), rose 7% and 8%, respectively.

  • [By Sean Williams]

    It just so happens that one of Canada’s top two players in the cannabis industry, Aurora Cannabis (NASDAQOTH:ACBFF), reported its third-quarter operating results on May 8 and updated investors on what to expect going forward. Given its importance to the domestic Canadian pot industry — the company expects to generate 430,000 kilograms of cannabis a year at full capacity — it pays to keep tabs on Aurora’s growth and how its projects are progressing. That said, here are the 10 things you should know about Aurora Cannabis’ Q3 report.

  • [By ]

    What are the risks? First off, the Cannabis market in Canada is already competitive, and it’s the fifth largest company behind the likes of Canopy (OTCPK:TWMJF), Aurora (OTCQX:ACBFF), Aphria (OTCQB:APHQF), Medreleaf (OTCPK:MEDFF), and Cronos (OTC:CRON). What’s more, there are approximately 228 million fully diluted shares, selling at $3.16/share ($4.04/share $CAD), and the company generated $CAD4.09mm in 2017 revenues. That’s quite a premium, and Hydropothecary Corp. trades expensively at a 225x sales multiple. Caveat emptor.

  • [By ]

    As we discussed the topic extensively in “The Complete Cannabis Guide #1: Production Cost”, Cronos reported its production cost similar to Aphria which includes overhead allocation and amortization. Other companies such as Canopy (OTCPK:TWMJF) and Aurora (OTCQX:ACBFF) report cash production cost which excludes non-cash costs such as amortization. Production cost was $2.18 per gram during the quarter, a very high number among the large peers. For reference Canopy reported production costs of $1.03 and Aphria reported $1.45 for its most recent quarter. The higher production cost was due to Cronos operating mostly indoor facilities compared to greenhouses. The greenhouse at Peace Naturals is very small with just 1,500 kg entering production during the second quarter, which should help bring down the production cost. Overall, Cronos is not and does not expect to become a low-cost producer, which is a concern especially given that the company has had to sell to the wholesale market for lower prices.